Portfolio company
ybiologics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops antibody-based therapeutics and immuno-oncology drugs for pharmaceutical partners and the global healthcare sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
imbiologics
The company develops antibody therapeutics for autoimmune diseases and cancer, providing these biological medicines to pharmaceutical firms and healthcare providers.
ABL Bio
The company develops bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases for pharmaceutical partners and clinical research applications.
Zymeworks
The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.
AbCellera Biologics
The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.
Abologix
The company develops monoclonal antibody therapeutics to treat drug-resistant lymphomas and solid tumours for cancer patients.
Lead Biologics
The company develops antibody-based immunotherapies for cancer and autoimmune diseases, targeting pharmaceutical firms and research institutions for early-stage development and collaboration.
Eubiologics
This biopharmaceutical company manufactures vaccines for global health organisations and provides contract research and manufacturing services to the biotechnology industry.
Crescendo Biologics
This company develops antibody fragment therapeutics for oncology and immunology patients and provides drug discovery collaborations to global biopharmaceutical partners.